BioCryst to Present Data at 2021 American Academy of Allergy, Asthma & Immunology Annual Meeting
RESEARCH TRIANGLE PARK, N.C., Feb. 09, 2021 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that data on...
News
Venus Concept Inc. to Participate in the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference on February 17th
TORONTO, Feb. 09, 2021 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology...
COMPASS Pathways expands its Discovery Center through new collaborations with world-leading scientists
COMPASS Pathways expands its Discovery Center through new collaborations with world-leading scientists Adam Halberstadt and John McCorvy join Jason Wallach to...
Amarin Provides Update on VASCEPA® (Icosapent Ethyl) Regulatory Review Processes in Mainland China and Hong Kong
DUBLIN, Ireland and BRIDGEWATER, N.J., Feb. 09, 2021 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that its corporate...
Monopar Announces Issuance of Patent Covering Composition of Matter for MNPR-101 in Canada
WILMETTE, Ill., Feb. 09, 2021 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company primarily focused on developing...
Rockwell Medical Announces U.S. Availability of Triferic® AVNU for Replacement of Iron and Maintenance of Hemoglobin in Patients on Hemodialysis
Triferic AVNU Triferic® AVNU (ferric pyrophosphate citrate injection), the intravenous (IV) formulation of Triferic, is now available in the United...
February is Heart Health Month: build awareness & prevent heart disease with the MUHC’s Women’s Healthy Heart Initiative (WHHI)
Women’s Healthy Heart Initiative Heart Health Month at the MUHC Foundation MONTREAL, Feb. 09, 2021 (GLOBE NEWSWIRE) -- February is...
Melt Pharmaceuticals Completes Phase 1 Study for Sublingual, Non-Opioid Pain and Sedation Drug Candidate
Company Expects to Begin Phase 2 Clinical Study in the Third Quarter of 2021BOSTON, Feb. 09, 2021 (GLOBE NEWSWIRE) --...
Skylight Health Names Paul Kulas Senior Vice President of Operations
TORONTO, Feb. 09, 2021 (GLOBE NEWSWIRE) -- Skylight Health Group Inc (TSXV:SHG ; OTCQX:SHGFF) (“Skylight Health” or the “Company”), announced...
Microbix Announces Material First Sales of Viral Transport Medium
Initial Production of 50,000 Vials Entirely SoldMISSISSAUGA, Ontario, Feb. 09, 2021 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQB:...
Eloxx Announces Publication of Scientific Manuscript on ELX-02 in the Journal of Cystic Fibrosis
Publication titled: “Targeting G542X CFTR Nonsense Alleles With ELX-02 Restores CFTR Function in Human-Derived Intestinal Organoids”WALTHAM, Mass., Feb. 09, 2021...
Sio Gene Therapies Announces Financial Results for Third Fiscal Quarter Ended December 31, 2020
- Company had $81 million of cash and cash equivalents as of December 31, 2020, and expects to receive additional...
Orchard Therapeutics Announces Interim Data for OTL-203 Showing Positive Clinical Results in Multiple Disease Manifestations of Mucopolysaccharidosis Type I Hurler Syndrome (MPS-IH)
All eight patients treated with OTL-203 show stable cognitive function, motor function and growth within the normal range at multiple...
MEDIA ADVISORY: Wear red for women’s heart health: National day of awareness February 13
Heart disease is still the number one killer of women, yet women are under-studied, under-treated, underdiagnosed, and under-aware when it...
AzurRx BioPharma Engages PPD to Manage Clinical Trial for Niclosamide as Treatment for COVID-19 Gastrointestinal Infections
Phase 2 Study of oral niclosamide planned for 1H 2021 DELRAY BEACH, Fla., Feb. 09, 2021 (GLOBE NEWSWIRE) -- AzurRx...
Acasti Pharma Announces Results for Third Quarter of Fiscal 2021
LAVAL, Quebec, Feb. 09, 2021 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti or the “Company”) (NASDAQ: ACST – TSX-V: ACST)...
Notice to the Annual General Meeting of Orion Corporation
ORION CORPORATION STOCK EXCHANGE RELEASE / NOTICE TO ANNUAL GENERAL MEETING 9 FEBRUARY 2021 at 12:15 EET Notice to the...
InspireMD Appoints Leading Interventional Cardiologist Chris Metzger, M.D. as Principal Investigator for CGuard Registration Trial in the United States
TEL AVIV, Israel, Feb. 09, 2021 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention...
Philips successfully completes tender offer for BioTelemetry, Inc.
February 9, 2021 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG; AEX: PHIA), a global leader in health technology, today...
Orion Group Financial Statement Release for 2020
ORION CORPORATION FINANCIAL STATEMENT RELEASE 2020 9 FEBRUARY 2021 at 12:00 Orion Group Financial Statement Release for 2020 This...